Skip to content
Delayed ~15 min

PRTA PROTHENA PLC

Health Care · Russell 2000

Next earnings: not announced yet

What 12 analyst firms say about PROTHENA PLC: their latest ratings, price targets and how far the stock is from them. How it works

7.97 USD+0.08 (+1.01%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+161.7%to the avg target 20.86 USD+12.89 USD
Buy 6 · Hold 3 · Sell 0

9 rated views · 12 analyst/firm records · 12 firms

Latest report7 Aug 2026avg report date 3 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8052
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8035

Recent analyst activity · last 90 days

Our tracked history has 2 reports on PRTA from 1 analyst firm in the last 90 days (12 firms in the past year).

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldEric SchmidtHold23 Mar 2026—
Chardan Capital MarketsRudy LiBuy19 Nov 2025—
CitigroupUnnamed analystBuy8 May 2026—
Citizens JMPJason ButlerBuy8 May 202620.00 USD
Deutsche BankUnnamed analyst—1 Dec 202519.00 USD
H.C. WainwrightAndrew S FeinBuy24 Jul 202630.00 USD
Piper SandlerYasmeen RahimiBuy6 Aug 202636.00 USD
RBC Capital MarketsBrian AbrahamsHold7 Aug 202613.00 USD
StifelUnnamed analyst—13 Mar 202619.00 USD
UBSUnnamed analystBuy24 Jul 2026—
Weiss RatingsUnnamed analyst—29 Oct 2026—
Data feed RESEARCHResearch TeamHold19 Feb 20269.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 07:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.